Registering a Class C medical device in Saudi Arabia involves complying with the regulatory framework established by the Saudi Food and Drug Authority (SFDA). Here's a step-by-step guide on how to handle the registration, including requirements, procedures, timelines, and practical tips.
Regulatory Body:
Saudi Food and Drug Authority (SFDA)
Website: https://sfda.gov.sa
Regulation:
SFDA operates under the Medical Devices Interim Regulation, and all medical devices must be registered in the MDMA (Medical Device Marketing Authorization) system.
Classification:
Class C devices are moderate-to-high risk devices (e.g., infusion pumps, bone fixation plates, etc.), subject to more detailed regulatory scrutiny.
If you are a foreign manufacturer, you must appoint a local Saudi Authorized Representative to interface with the SFDA.
Communicating with SFDA on your behalf
Submitting documentation
Handling adverse event reporting and recalls
Ensuring post-market compliance
For both Manufacturer and AR:
Establishment License (EL): Required for all entities involved in importing, distributing, or marketing medical devices.
The EL must be obtained via the GHAD System on the SFDA platform.
You can submit a classification consultation request to SFDA to confirm your device is indeed Class C. This ensures you're applying through the correct regulatory pathway.
Prepare the Required Technical Documentation:
Description and intended use of the device
Classification rationale
Risk management documentation (ISO 14971)
Clinical evaluation report (CER) or literature
Post-market surveillance plan
Labeling and Instructions for Use (Arabic and English)
Manufacturing Quality Management Certificate (ISO 13485)
Free Sale Certificate from country of origin
Declaration of Conformity
Submit Through SFDA MDMA Portal:
Upload documents
Provide device identifiers (e.g., GMDN/UDI codes)
Pay the registration fee (see below)
Undergo Technical File Review:
SFDA will evaluate compliance with applicable GHTF, IMDRF, and Saudi requirements.
Fees depend on the risk class and number of devices:
For Class C: Generally around 8,000–15,000 SAR (approx. $2,000–$4,000 USD) per device configuration.
Check the exact fee structure on SFDA’s fee schedule.
Timeframe:
Typically 4–6 months, depending on completeness of submission and SFDA workload.
Outcome:
Once approved, you will receive a Medical Device Marketing Authorization (MDMA) license.
Once approved, you must comply with:
Vigilance reporting (reporting adverse events and incidents)
Annual update/reporting
Post-market surveillance and possibly local clinical studies
Renewal of MDMA License before expiry (valid for 3 years typically)
| Document | Required |
|---|---|
| ISO 13485 Certificate | ✅ |
| Free Sale Certificate | ✅ |
| Device Technical File | ✅ |
| Labeling & IFU (Arabic + English) | ✅ |
| Risk Management Report | ✅ |
| Clinical Evaluation Report | ✅ |
| Authorized Representative Agreement | ✅ |
| Declaration of Conformity | ✅ |
Use a local consultant or AR experienced with SFDA to avoid common errors.
Ensure that your documentation matches GHTF/IMDRF formats (SFDA is a GHTF member).
Translate all labeling and IFU into Arabic per local regulations.
Consider leveraging existing approvals (FDA 510(k), CE, TGA) to support your submission.
Submitting outdated ISO or CE certificates
Not using the correct GMDN/IMDRF coding
Misclassifying the device (Class C vs B/D)
Incomplete Arabic translation of labeling
Delays in payment or technical responses
| Stage | Time Estimate |
|---|---|
| Appoint AR + Establishment License | 2–4 weeks |
| Prepare MDMA Submission | 4–8 weeks |
| SFDA Review | 3–6 months |
| Total Time | 5–8 months (typical) |

Whatsapp or Wechat:+86 15816864648;email address:hito.lin@grzan.cn